These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 22483773)
21. Pulmonary Arterial Hypertension: What Rare Diseases Tell Us About Disparities in Disease Registries, Clinical Trials, and Treatment Algorithms. Goel K; Hon SM; Farber HW; George MP Chest; 2021 Nov; 160(5):1981-1983. PubMed ID: 34743846 [No Abstract] [Full Text] [Related]
22. Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov. Hee SW; Willis A; Tudur Smith C; Day S; Miller F; Madan J; Posch M; Zohar S; Stallard N Orphanet J Rare Dis; 2017 Mar; 12(1):44. PubMed ID: 28253932 [TBL] [Abstract][Full Text] [Related]
23. [Purposefulness of using fuzzy logic approaches in the rare disease clinical trials]. Kiseleva TS; Pagava KI; Korinteli IA; Korinteli MG; Shonvadze DN Georgian Med News; 2011 Apr; (193):22-4. PubMed ID: 21617269 [TBL] [Abstract][Full Text] [Related]
24. [Rare diseases, a public health issue]. Donnart A; Viollet V; Roinet-Tournay M Soins Pediatr Pueric; 2013; (274):17-9. PubMed ID: 24228329 [TBL] [Abstract][Full Text] [Related]
25. Specialized teams or specialist networks for rare cancers? Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223 [No Abstract] [Full Text] [Related]
27. [Documentary research and self-instruction. Critical reading of a medical article. Practice guidelines. Part 1: rare diseases]. Cordier JF; Aymé S Rev Prat; 2004 Apr; 54(7):777-9. PubMed ID: 15253297 [No Abstract] [Full Text] [Related]
28. Clinical trials and methodological problems in prion diseases. Puopolo M; Pocchiari M; Petrini C Lancet Neurol; 2009 Sep; 8(9):782; author reply 782-3. PubMed ID: 19679270 [No Abstract] [Full Text] [Related]
29. Sample size estimation for non-inferiority trials of time-to-event data. Crisp A; Curtis P Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558 [TBL] [Abstract][Full Text] [Related]
30. [Towards a better organisation of care for rare diseases in France : a ministry perspective]. Chevrier A Med Sci (Paris); 2018 May; 34 Hors série n°1():9-10. PubMed ID: 29911544 [No Abstract] [Full Text] [Related]
31. [Round table 2. The evolutions following the implementation of the law for health and sanitary security]. Med Sci (Paris); 2014 Apr; 30 Spe(1):14-20. PubMed ID: 24755172 [No Abstract] [Full Text] [Related]
32. Pediatric pancreatic tumors: the orphan looking for a home. Brennan B Pediatr Blood Cancer; 2010 May; 54(5):659-60. PubMed ID: 20063425 [No Abstract] [Full Text] [Related]
33. [Workshops A1 to A5]. Med Sci (Paris); 2014 Apr; 30 Spe(1):33-9. PubMed ID: 24755177 [No Abstract] [Full Text] [Related]
35. Clinical trial methodology in rare gynecologic tumor research: Strategies for success. Brown J; Naumann RW; Brady WE; Coleman RL; Moore KN; Gershenson DM Gynecol Oncol; 2018 Jun; 149(3):605-611. PubMed ID: 29699802 [TBL] [Abstract][Full Text] [Related]
36. [Current status of the French National Data Repository in the field of Rare Diseases]. Salamanca E Med Sci (Paris); 2018 May; 34 Hors série n°1():26. PubMed ID: 29911550 [No Abstract] [Full Text] [Related]
37. [Rare tumours: a new heading in Bulletin du cancer]. Massard C; Droz JP Bull Cancer; 2010 Sep; 97(9):1031-9. PubMed ID: 20813656 [TBL] [Abstract][Full Text] [Related]
39. Methodology of clinical trials for rare diseases. Tudur Smith C; Williamson PR; Beresford MW Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061 [TBL] [Abstract][Full Text] [Related]
40. Need to improve clinical trials in rare neurodegenerative disorders. Puopolo M; Pocchiari M Ann Ist Super Sanita; 2011; 47(1):55-9. PubMed ID: 21430340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]